Cargando…
Consideration in treatment decisions for refractory Mycoplasma pneumoniae pneumonia
Mycoplasma pneumoniae (MP) is the most common cause of childhood bacterial pneumonia. Although macrolide is known to be effective as a first-line therapy, the proportion of macrolide resistance in MP pneumonia has strikingly increased during recent 2 decades in East Asia. This is challenging to phys...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Pediatric Society
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426095/ https://www.ncbi.nlm.nih.gov/pubmed/33561337 http://dx.doi.org/10.3345/cep.2020.01305 |